Wageningen, Denmark—In a recent study conducted by Top Institute Food and Nutrition in Wageningen, researchers discovered that probiotic bacteria found in yogurt drinks change once in the intestines, thereby supporting digestive health.
Ithaca, NY and Augusta, GA—New studies have shown that maternal intake of the nutrient choline during pregnancy can have a positive impact on the neural functions of children born with Down syndrome, as well as those whose mothers consumed alcohol during the first trimester. Choline, found in egg yolks, liver, nuts, broccoli and cauliflower, is part of several major phospholipids that are critical for normal membrane structure and function according to the Journal of Nutrition Web site. This nutrient is also present in numerous brain support supplements.
Washington, D.C.—A new legislative bill is on the table that would give dietary supplement makers the ability to reference additional scientific information about the health benefits of their products.
New York, NY—Memorial Sloan-Kettering Cancer Center will launch a phase-II trial to study Maitake mushroom as a treatment for Myelodysplastic Syndrome (MDS), a category of blood diseases. Maitake has been studied previously for its effects on immune system function.
Boston, MA—Consumers are familiar with product labels touting the heart healthy benefits of eating oats. They most famously lower blood cholesterol and are an important part of a heart-healthy diet. An expanding field of research into oats and their benefits is shedding light on reasons for oats to impress even more enthusiasts.
Tours, France—Another health application of omega-3 fatty acids has been identified, this time proving a beneficial component in helping women undergoing breast cancer treatment. Specifically, docosahexaenoic acid (DHA) was found to increase the effectiveness of chemotherapy treatment for certain cases of breast cancer. The findings were published late last year in the British Journal of Cancer, and may present a means to better combat breast cancer for the millions threatened by the disease, which is the most prevalent form of cancer in women. The research was led by Philippe Bougnoux, of the Henry S. Kaplan Cancer Center in Tours.